NCT07023354View on ClinicalTrials.gov

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

March 20, 2026

Study Completion Date

March 20, 2026

Conditions
HealthyHepatic Impairment
Interventions
DRUG

BI 1291583

BI 1291583

Trial Locations (3)

32809

RECRUITING

Orlando Clinical Research Center, Orlando

77598

NOT_YET_RECRUITING

Tranquil Clinical Research, Houston

78215

RECRUITING

American Research Corporation at the Texas Liver Institute, San Antonio

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY